Risk literacy and choices – stubbing toes in the dark

In the midst of uncertainty, risk literacy can help us make the right decisions in an informed way. Risk literacy is the ability to perceive risks and the aptitude to make appropriate decisions after becoming aware of these risks. To measure risk literacy during the Covid-19 crisis, we asked almost 7,000 people in seven countries questions related to numeracy and risk literacy, as well as about the impact of the pandemic on their finances. 

 

Digital-enabling countries proved more resilient to the Covid-19 economic shock

The higher the digitization of your country or company, the higher the resilience of this country or company in a context of Covid-19. The Euler Hermes Enabling Digitalization Index (EDI) measures the ability – and agility – of countries to help digital companies thrive and traditional businesses harness the digital dividend. 

 

Italy: Draghinomics FAQs

As Italy’s next Prime Minister, former ECB President Mario Draghi starts with a double economic burden: weak growth momentum and a vaccination delay that could cost EUR10bn (0.6% of GDP). 

 

Is the Chinese Ox reflating the world, one container at a time?

Amid surging demand for imports from China, a container shortage and a strengthening RMB are pushing up import prices for European firms: We expect a peak of +6% y/y by end-April 2021 from +3% in November 2020. For the US, the impact should be milder: +2% y/y by July from -1% in November.

 

China: Riding the silicon ox?

The recent shortages of chips used in the automotive industry highlight the growing ubiquity and critical nature of semiconductors, which are the essential components that power the USD3,000bn IT industry.

 

Big Oil: At risk of becoming fossil firms?

Turning off the (profit) tap. After a year of low oil prices and low demand that pushed most major oil companies into losses, the hit to profitability will continue in 2021 and 2022. 

 

Covid-19 vaccines: A USD40bn revenue windfall for pharmaceuticals

The race to find a cure for Covid-19 saw an estimated USD25bn spent on pharmaceutical R&D in 2020 alone, with half coming from the US’s "Operation Warp Speed".

 

Vaccination delay to cost Europe EUR90bn in 2021

After finishing 2020 on a high note with a vaccine light at the end of the tunnel, Europe now faces a moment of truth: a five-week delay on the vaccination front that, if left uncorrected, could cost close to EUR90bn in 2021. 

 

Allianz Pension Report: Asia special 2021

The Asia-Pacific region has fared better than most other regions during the Covid-19 crisis: Economic activity is likely to have declined by less than -2% in 2020, compared to more than -4% at the global level and almost -8% in Latin America. 

 

The hot race for green tech dominance

For the EU, US and China, the Covid-19 recovery is an opportunity to accelerate in the race to dominate energy transition industries and boost sustainable growth and job opportunities.